Neurent Medical

Galway-based medtech company behind NEUROMARK, a minimally invasive device for chronic rhinitis.

View on the globe

$74MEquity raised in 2025–20262025 — · 2026 $74M · 1 equity round
$74MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 11 Feb 2026 to 11 Feb 2026, $74M equity disclosed. Earlier rounds exist but are not sourced.11 Feb 2026: Series C, $74M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ3Q42026Q2Q3Q4Equity round11 Feb 2026 · Series C · $74M · led by MVM PartnersSeries C · $74M
Funding history: 1 round from 11 Feb 2026 to 11 Feb 2026, $74M equity disclosed. Earlier rounds exist but are not sourced.11 Feb 2026: Series C, $74M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourcedQ42026Q2Q3Q4Equity round11 Feb 2026 · Series C · $74M · led by MVM Partners$74M

Funding history 1 round · 2 sources

Earlier rounds not yet sourced. Neurent Medical raised before 11 Feb 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series C
    Amount$74MEUR 62.5M
    Post-money—
    ✓ Confirmed
    Lead
    MVM Partners
    Also
    Sofinnova Partners, EQT, Atlantic Bridge, Fountain Healthcare Partners, Enterprise Ireland
    Note
    Company release (PR Newswire, dateline Galway and Braintree, Feb 11 2026): EUR 62.5M ("$74 million" as stated in the release; the USD figure is the release's own conversion). Sofinnova release confirms its significant participation. Release names "EQT Life Sciences", recorded as the registry firm EQT. Founding year not stated in the release. Earlier rounds (a 2021 Series B, reportedly led by LSP) seen only in a search snippet and not sourced: historyComplete false. A EUR 21M "Other" row dated 2026-09-09 (Claret Capital Partners) is database-only: not written.
    Sources
  2. Earlier rounds not yet sourced

Investors 6

  • MVM Partners1
  • Atlantic Bridge
  • Enterprise Ireland
  • EQT
  • Fountain Healthcare Partners
  • Sofinnova Partners

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Neurent Medical and its logo are trademarks of their owners, used here for identification only.